Centre for Health Policy, School of Population and Global Health, the University of Melbourne, Melbourne, VIC.
VCS Foundation, Melbourne, VIC.
Med J Aust. 2021 Oct 18;215(8):354-358. doi: 10.5694/mja2.51137. Epub 2021 Jun 18.
To evaluate the implementation and acceptability of the self-collection cervical screening pathway since commencement of the renewed National Cervical Screening Program (rNCSP), from the perspectives of screening participants and primary care practitioners.
DESIGN, SETTING, PARTICIPANTS: Qualitative study; individual semi-structured interviews with 45 screening participants and 18 primary care practitioners in Victoria who had engaged with the self-collection pathway during the first 17 months of the rNCSP (1 December 2017 - 30 April 2019).
The self-collection pathway was highly acceptable as an alternative cervical screening pathway for most participating screening participants and practitioners. Some screening participants indicated that they would not have been screened had the pathway not been available. Acceptability was lower among those who had tested positive for HPV types not 16/18, a result that requires additional testing of a clinician-collected cervical sample. Use of the self-collection pathway is driven more by practitioners than their patients. Interpretations of the self-collection guidelines varied between practices. Barriers to expanding promotion of the pathway by practitioners included difficulties with identifying eligible participants.
Increasing the accessibility of the self-collection pathway to under- and never screened women could reduce inequities in cervical cancer outcomes for those not participating in the main screening pathway. Practitioners should be provided resources to integrate self-collection into routine practice and to efficiently implement the entire self-collection pathway, in order to maximise its use and to optimise the experience for screening participants.
从筛查参与者和初级保健医生的角度评估自取样宫颈癌筛查途径在国家宫颈癌筛查计划(rNCSP)更新后的实施情况和可接受性。
设计、地点、参与者:定性研究;对 45 名筛查参与者和 18 名维多利亚初级保健医生进行个体半结构化访谈,他们在 rNCSP 的前 17 个月(2017 年 12 月 1 日至 2019 年 4 月 30 日)使用了自取样途径。
自取样途径对于大多数参与筛查的参与者和医生来说,是一种替代的宫颈癌筛查途径,具有较高的可接受性。一些筛查参与者表示,如果没有这种途径,他们将不会接受筛查。对于那些 HPV 16/18 以外的类型检测呈阳性的人,可接受性较低,这需要对临床医生采集的宫颈样本进行进一步检测。自取样途径的使用更多地是由医生驱动,而不是他们的患者。各实践对自取样指南的解释存在差异。医生扩大推广自取样途径的障碍包括难以确定符合条件的参与者。
增加未筛查和从未筛查过的女性使用自取样途径的可及性,可能会减少那些未参与主要筛查途径的人在宫颈癌结果方面的不平等。应向医生提供资源,将自取样纳入常规实践,并有效地实施整个自取样途径,以最大限度地利用该途径,并优化筛查参与者的体验。